Pages that link to "Q114999705"
Jump to navigation
Jump to search
The following pages link to Laura Bellodi (Q114999705):
Displaying 50 items.
- Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture (Q21090200) (← links)
- No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene. (Q33184756) (← links)
- Smoking and respiratory irregularity in panic disorder (Q33206757) (← links)
- Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype. (Q34022011) (← links)
- Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations (Q34317224) (← links)
- Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study (Q34445382) (← links)
- Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. (Q34807118) (← links)
- Understanding obsessive-compulsive disorder: focus on decision making (Q36481680) (← links)
- Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders (Q37342734) (← links)
- Evaluation of Mother-Child Agreement and Factorial Structures of the SCARED Questionnaire in an Italian Clinical Sample (Q37662535) (← links)
- Novel antidepressants and panic disorder: evidence beyond current guidelines (Q37801794) (← links)
- Planning functioning and impulsiveness in obsessive-compulsive disorder (Q38688300) (← links)
- Smoking, physical activity and respiratory irregularities in patients with panic disorder. (Q39346480) (← links)
- Supporting tools in psychiatric treatment decision-making: sertraline outcome investigation with artificial neural network method (Q40429438) (← links)
- Frontal lobe dysfunction in pathological gambling patients (Q40646097) (← links)
- Evaluating effect of symptoms heterogeneity on decision-making ability in obsessive-compulsive disorder (Q41671703) (← links)
- Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study (Q42641687) (← links)
- Motor inhibition and cognitive flexibility in eating disorder subtypes (Q43492290) (← links)
- Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism (Q43938287) (← links)
- Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome (Q43990364) (← links)
- Are gender differences in antiobsessional response related to different clomipramine metabolism? (Q43990382) (← links)
- The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: an open study (Q44289073) (← links)
- Serotonergic modulation of the balance system in panic disorder: an open study (Q44351510) (← links)
- Neurosteroid secretion in panic disorder (Q44473307) (← links)
- Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study. (Q44547216) (← links)
- Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study (Q44876361) (← links)
- Decision-making functioning as a predictor of treatment outcome in anorexia nervosa (Q44980098) (← links)
- Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder (Q44993060) (← links)
- Bulimia nervosa, 5-HTTLPR polymorphism and treatment response to four SSRIs: a single-blind study. (Q45147157) (← links)
- Selective serotonin re-uptake inhibitors beyond psychiatry: are they useful in the treatment of severe, chronic, obstructive pulmonary disease? (Q45219394) (← links)
- Artificial neural network model for the prediction of obsessive-compulsive disorder treatment response. (Q45932129) (← links)
- The advantages of choosing antiobsessive therapy according to decision-making functioning (Q46227471) (← links)
- Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: a European multicenter study. (Q46525735) (← links)
- In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. (Q46568434) (← links)
- Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene (Q46611107) (← links)
- Investigation of the serotonin transporter regulatory region polymorphism in bulimia nervosa: relationships to harm avoidance, nutritional parameters, and psychiatric comorbidity (Q46921458) (← links)
- Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. (Q47211100) (← links)
- Panic disorder: from respiration to the homeostatic brain (Q47347645) (← links)
- Factors of risk and maintenance for eating disorders: psychometric exploration of the cross-cultural questionnaire (CCQ) across five European countries. (Q47355898) (← links)
- Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa (Q47383170) (← links)
- Associations of individual and family eating patterns during childhood and early adolescence: a multicentre European study of associated eating disorder factors. (Q47660735) (← links)
- Language of dyspnea in panic disorder (Q47926704) (← links)
- Carbon dioxide-induced panic attacks and quantitative electroencephalogram in panic disorder patients (Q48390841) (← links)
- Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations (Q49137557) (← links)
- A new social-family model for eating disorders: A European multicentre project using a case-control design (Q50568816) (← links)
- Temperament, character and anxiety sensitivity in panic disorder: a high-risk study (Q50569143) (← links)
- Emotional intelligence in panic disorder. (Q50647030) (← links)
- Anxiety sensitivity and 35% CO2 reactivity in patients with panic disorder. (Q51024314) (← links)
- Approximate entropy of respiratory patterns in panic disorder. (Q51636471) (← links)
- Respiration in children at risk for panic disorder. (Q51728811) (← links)